original sequence of the backbone of semaglutide (Figure 1)
[DOI] [PubMed] [Google Scholar] 34.Halpner A.D., Handelman G.J., Harris J.M., Belmont C.A., Blumberg J.B
manufacturing expansion, as the company gears up for a GLP-1 pill showdown with Novo Nordisk
Nevertheless, according to the European Medicines Agencys (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) findings from October 2023, there is no evidence to suggest a causal relationship between GLP-1 receptor agonists (including exenatide, liraglutide, dulaglutide, semaglutide, and lixisenatide) and thyroid cancer [56]
Some patients may experience taste changes that go unreported unless specifically asked, or they may attribute the symptom to other causes